The Journal of infectious diseases · 2026
Regulatory T-Cell Notch4 Expression Correlates With Mortality in Patients Hospitalized With COVID-19.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Alkarkoukly Samer, Hambo Shadi, Menk Mario, Spieth Peter, Antczak Philipp, Harb Hani
Аннотация
BACKGROUND: Severe COVID-19 is characterized by profound immune dysregulation, yet the mechanisms distinguishing fatal from nonfatal outcomes remain incompletely understood. Regulatory T (Treg) cells have been shown to play a central role in regulating immune responses and promoting tissue repair. In this study, we investigate the expression of Notch4 on peripheral circulating Treg cells in 169 patients hospitalized with COVID-19 and evaluate its association with clinical outcomes.
RESULTS: Our analysis divulges that Notch4 expression on Treg cells correlates significantly with death in patients after 6 weeks of intensive care unit (ICU) admission, correlating with hypoxia, immunosuppression, and multiple-organ failure. Unlike early-phase inflammatory cytokines such as IL-6, IL-8, and IL-10-whose upregulation was observed during the first 2 weeks-Notch4 expression emerges as a late marker, specifically distinguishing patients who eventually succumb to the disease. Similar to earlier reports, deeper immune profiling of regulatory cells identified a shift of both Treg and T follicular regulatory cells in patients who died toward a proinflammatory profile, suggesting phenotypic reprogramming. In our previous studies, Notch4 expression was strongly associated with decreased regulatory capacity and increased immune activation. Our results indicate that persistent Notch4+ Treg signatures, particularly after 6 weeks of ICU admission, serve as critical markers of mortality in COVID-19.
CONCLUSIONS: Notch4 can be used as a viable therapeutic target to restore immune homeostasis in patients who are critically ill. Further studies are still needed to understand the role of Treg cell Notch4 expression in other viral acute respiratory distress syndromes.
RESULTS: Our analysis divulges that Notch4 expression on Treg cells correlates significantly with death in patients after 6 weeks of intensive care unit (ICU) admission, correlating with hypoxia, immunosuppression, and multiple-organ failure. Unlike early-phase inflammatory cytokines such as IL-6, IL-8, and IL-10-whose upregulation was observed during the first 2 weeks-Notch4 expression emerges as a late marker, specifically distinguishing patients who eventually succumb to the disease. Similar to earlier reports, deeper immune profiling of regulatory cells identified a shift of both Treg and T follicular regulatory cells in patients who died toward a proinflammatory profile, suggesting phenotypic reprogramming. In our previous studies, Notch4 expression was strongly associated with decreased regulatory capacity and increased immune activation. Our results indicate that persistent Notch4+ Treg signatures, particularly after 6 weeks of ICU admission, serve as critical markers of mortality in COVID-19.
CONCLUSIONS: Notch4 can be used as a viable therapeutic target to restore immune homeostasis in patients who are critically ill. Further studies are still needed to understand the role of Treg cell Notch4 expression in other viral acute respiratory distress syndromes.